MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY
R. Campi, Maria Carmen Mir(Fundación Instituto Valenciano de Oncología), Lulin Ma(Peking University), Riccardo Bertolo(University of Verona), Tobias Maurer(Universität Hamburg), Francesco Porpiglia(University of Turin), Estefanía Linares(Hospital Universitario La Paz), M. Albertsen(KU Leuven), Umberto Capitanio(Vita-Salute San Raffaele University), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Autorino(Rush University Medical Center), Maximilian C. Kriegmair(University Medical Centre Mannheim), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Nicola Pavan(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Francesco Claps(University of Trieste), E. Rousel(University of California San Diego), J. Rubió, Ithaar Derweesh(Rush University Medical Center), Vital Hevia(Hospital Universitario Ramón y Cajal), Shudong Zhang(Peking University), Tobias Klatte(Helios Hospital Bad Saarow)
Cited by 0
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256